TRONDHEIM, Norway--(BUSINESS WIRE)--Bruker has installed two nuclear magnetic resonance (NMR) spectrometers for metabolic profiling at the new MR Metabolomics Laboratory at the NTNU hospital campus in Trondheim. Metabolic profiling of tissue samples and biofluids has the potential to transform the way cancer diagnostics and treatments are optimized for individual patients. The new NMR systems will enable scientists at NTNU’s Faculty of Medicine, working in partnership with clinicians at St. Olavs University Hospital, to investigate tissue samples and biofluids from patients taking part in studies, or from model systems of the same diseases. Researchers will use the NMR instrumentation for rapid, high-throughput analyses, aiming for characterisation, treatment planning and monitoring of cancer patients. The ultimate goal is to investigate whether this methodology can provide clinicians with more detailed diagnostic information that can improve treatment for an individual patient.
